• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down 0.49% Nasdaq Up 0.07%

    Nivalis Therapeutics, Inc. (NVLS)

    -NasdaqGM
    4.90 Up 0.12(2.51%) 12:33PM EDT
    Prev Close:4.78
    Open:4.80
    Bid:4.81 x 100
    Ask:4.90 x 400
    1y Target Est:25.00
    Beta:1.46
    Earnings Date:Aug 1 - Aug 5 (Est.)
    Day's Range:4.80 - 4.95
    52wk Range:3.68 - 20.43
    Volume:8,771
    Avg Vol (3m):45,081
    Market Cap:75.76M
    P/E (ttm):N/A
    EPS (ttm):-2.08
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for NVLS

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):N/A
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-16) :-2.17
    Quarterly EPS Est (Jun-16) :-0.52
    Mean Recommendation*:1.3
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Nivalis Therapeutics, Inc., a clinical stage pharmaceutical company, focuses on the discovery, development, and commercialization of product candidates for patients with cystic fibrosis (CF). View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback